Baijin Life Science Holdings Limited (HKG:1466)

HKG:1466 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	43.11	47.77	37.88	41.26	23.59
Short-Term Investments	0.93	0.8	0.71	0.59	0.59
Cash & Short-Term Investments	44.04	48.57	38.59	41.85	24.17
Cash Growth	-9.33%	25.85%	-7.78%	73.13%	-3.17%
Accounts Receivable	15.05	25.93	15.89	7.02	5.67
Other Receivables	44.62	71.12	14.34	0.42	20.9
Receivables	59.67	97.05	30.23	7.44	26.56
Inventory	58.28	70.64	44.34	44.61	23.98
Prepaid Expenses	30.1	10.74	8.16	4.98	4.84
Total Current Assets	192.09	227	121.32	98.87	79.56
Property, Plant & Equipment	30.74	16.84	8.78	0.98	2.55
Long-Term Investments	1.11	-	-	-	-
Goodwill	15.36	28.36	48.36	-	-
Other Intangible Assets	4.59	5.91	7.35	-	-
Long-Term Deferred Tax Assets	1.09	0.94	0.04	-	-
Other Long-Term Assets	19.46	11.13	10.95	-	-
Total Assets	264.44	290.17	196.8	99.85	82.11

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	10.13	8.34	7.87	9.01	4.6
Accrued Expenses	8.92	7.04	4.15	0.44	1.45
Short-Term Debt	13.68	12.56	9.42	2	29.78
Current Portion of Leases	9.23	5.08	1.11	0.76	1.28
Current Income Taxes Payable	0.48	1.28	1.53	-	-
Current Unearned Revenue	3.27	3.04	4.75	-	-
Other Current Liabilities	18.91	12.38	12.16	8.87	8.36
Total Current Liabilities	64.63	49.72	40.99	21.08	45.46
Long-Term Debt	-	75.28	39.71	-	-
Long-Term Leases	5.5	7.01	0.95	-	0.78
Pension & Post-Retirement Benefits	0.91	0.77	0.47	0.49	-
Long-Term Deferred Tax Liabilities	1.15	1.51	1.89	-	-
Total Liabilities	72.18	134.3	84.01	21.56	46.24

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	18.65	15.45	13.59	12.79	6.39
Additional Paid-In Capital	-	688.54	645.9	619.13	592.75
Retained Earnings	-	-559.94	-559.5	-560.81	-569.48
Comprehensive Income & Other	166.55	-4.76	-3.67	7.18	6.21
Total Common Equity	185.19	139.28	96.31	78.29	35.87
Minority Interest	7.06	16.59	16.48	-	-
Shareholders' Equity	192.25	155.88	112.79	78.29	35.87
Total Liabilities & Equity	264.44	290.17	196.8	99.85	82.11

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	28.41	99.93	51.19	2.76	31.84
Net Cash (Debt)	15.63	-51.36	-12.6	39.09	-7.67
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.02	-0.07	-0.02	0.06	-0.02
Filing Date Shares Outstanding	932.25	772.39	679.25	639.3	319.65
Total Common Shares Outstanding	932.25	772.39	679.25	639.3	319.65
Working Capital	127.46	177.28	80.33	77.8	34.09
Book Value Per Share	0.20	0.18	0.14	0.12	0.11
Tangible Book Value	165.24	105.01	40.6	78.29	35.87
Tangible Book Value Per Share	0.18	0.14	0.06	0.12	0.11
Machinery	-	8.77	28.8	23.37	23.34
Leasehold Improvements	-	3.93	2.22	0.54	0.54

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error